In 2018, 25% of FDA Drug GMP Warning Letters were sent to compounding pharmacies. Many of these letters (as well as 483s) were directly related to the cleaning and disinfecting practices and documentation. CCI has extensive experience in the cleaning/disinfecting of compounding pharmacies under USP 797 guidelines. We can maintain both hazardous and non-hazardous sterile compounding rooms, as well as anterooms and C-PECs and BSCs.